MedPath

Clinical study on the effect of adjuvant chemotherapy using TS-1 in the treatment of salivary gland carcinoma

Phase 2
Conditions
Salivary gland carcinoma
Registration Number
JPRN-UMIN000014070
Lead Sponsor
Department of Dentistry and Oral Surgery, Shinshu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

1) The possibility (will) of the pregnancy and nursing girl 2) Active multiple primary 3) Having a mental disorder 4) Having a serious or life-threatening disease. 5) Having uncontrolled diarrhea 6) Systemic steroid use 7) Having infection 8) Having fever up over 38 degree Celsius 9) Severe allergic reaction for any drugs 10) Taking flucytosine 11) Patients who need flucytosine, phenytoin, or warfarin. 12) Anyone who was judged as unsuitable for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival time
Secondary Outcome Measures
NameTimeMethod
Disease free survival time, Distant metastasis free survival time, adverse effect
© Copyright 2025. All Rights Reserved by MedPath